Rutgers University-Camden Wound Ostomy Continence Nurse Program
Rutgers University-Camden offers its Wound Ostomy Continence Nurse Program in both an online and on-campus format.
Read MoreHSP Resources
Industry News
Gel made out of a patient’s blood could help problem foot ulcers heal quicker
A gel made from blood could rapidly speed up the healing of chronic wounds. Problem foot ulcers treated with the gel, made from the patient’s own blood, are more likely to heal than those treated traditionally, according to a new study.
Read MorePressure Ulcer Education 4: Selection and Use of Support Surfaces
The use of support surfaces is one of the most common interventions for preventing pressure ulcers. These support surfaces can include mattresses, chairs, cushions, foot/heel protection and offloading. Nurses need to understand their impact on skin integrity, associated risk factors and how to select the correct equipment for a patient’s needs. This article discusses surface selection and use.
Read MoreHow Will Collagen Help Healing Wounds?
The increasing number of surgical site infections gives rise to the development of new surgical procedures in the U.S. Chronic wounds caused by diabetes do not heal quickly and often surface the wound with a wide range of bacteria in the form of biofilm. Biofilm bacteria are very tough to treat, and the antimicrobial resistance only stimulates the possibility of an infection in the wound.
Read MoreMothers Donating Placenta for Wound Care
New mothers are donating their placentas to help patients with diabetic ulcers, severe burns and chronic wounds. Organ donor network Lifeline of Ohio has been working with a small number of Ohio hospitals, including Lima Memorial Health System and Mercy Health-St. Rita’s Medical Center in Lima, to educate soon-to-be mothers about how their donated birth tissues can be used in wound care.
Read MoreBioresorbable Scaffold Effectively Treats Below-the-Knee Lesions
A bioresorbable scaffold was shown to be safe and effective for treatment of below-the-knee lesions in two studies presented at VIVA 19. In the 5-year results of the ABSORB BTK trial of the bioresorbable scaffold (Absorb, Abbott), more than 90% of patients did not require revascularization, whereas in the 1-year results of the DISAPEAR registry, there were high rates of patency, wound healing and limb salvage.
Read MoreKickstart Your Wound Care Specialist Training with PrepSmart
For nurses today, one of the biggest challenges to prepare for is caring for an increasing number of patients with chronic wounds, which can include diabetic foot ulcers, pressure ulcers and venous leg ulcers. In fact, an estimated 67 million people around the world are suffering with chronic wounds, making access to a wound care specialist of utmost importance to these patients.
Read MoreTailored ‘cell sheets’ to improve post-operative wound closing and healing
Scientists have designed a new method for post-operative wound closing and healing that is both fast and effective. This strategy revolves around engineered “cell sheets”—or layers of skin-based cells. The procedure culminates in a wound dressing that is custom made for a specific cut or lesion that can be used to effectively treat open skin areas after surgeries.
Read MoreCardiovascular Systems, Inc. Announces FDA Approval of the Coronary ViperWire Advance® With Flex Tip
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced U.S. Food and Drug Administration (FDA) PMA approval of the new ViperWire Advance® Coronary Guide Wire with Flex Tip (ViperWire Advance with Flex Tip).
Read MoreNuo Therapeutics Provides Update on Ongoing Interactions with Centers for Medicare & Medicaid Services
Nuo Therapeutics, Inc. today provided an update on ongoing interactions with Centers for Medicare & Medicaid Services’ (CMS) Coverage and Analysis Group (CAG) representatives. As previously disclosed by the Company, the discussions to date have centered around the feasibility of re-opening the national coverage determination (NCD) for autologous blood-derived products for chronic non-healing wounds.
Read More